Emergent Biosolutions Inc. EPS Growth (diluted)

EPS Growth (diluted) of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (diluted) growth rates and interactive chart. Year over year growth in diluted earnings per share.


Highlights and Quick Summary

  • EPS Growth (diluted) for the quarter ending June 30, 2023 was -355.75% (a -93.04% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (diluted) increased by 138.47%
  • Annual EPS Growth (diluted) for 2022 was -204.68% (a 729.0% increase from previous year)
  • Annual EPS Growth (diluted) for 2021 was -24.69% (a -105.55% decrease from previous year)
  • Annual EPS Growth (diluted) for 2020 was 445.19% (a -3118.24% decrease from previous year)
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (diluted) of Emergent Biosolutions Inc.

Most recent EPS Growth (diluted)of EBS including historical data for past 10 years.

Interactive Chart of EPS Growth (diluted) of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -355.75% -5114.29%
2022 -150.29% -149.18% -1355.56% -105.47% -204.68%
2021 1.74% -183.56% -94.8% 633.33% -24.69%
2020 286.52% -12.05% 1061.11% 52.94% 445.19%
2019 1371.43% 102.44% -118.37% -410.0% -14.75%
2018 -110.45% -39.71% 790.91% -143.48% -28.65%
2017 0.0% 51.11% 140.74% 130.0% 51.33%
2016 -5.63% -43.04% -184.38% 117.54% -19.86%
2015 7.58% 61.22% 146.15% -3.64% 60.23%
2014 60.98% 36.11% -55.17% -150.0% 3.53%
2013 -6.82% 100.0% 38.1% -15.79% 30.77%
2012 -43.59% 1.56%

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic